Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK

https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00028-8/fulltext?dgcid=hubspot_email_infocusalerts-psychiatry_feature&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz--ofe4gb59cWa532QwpPYo0JrxPyiEx009VP3wia-Q4fN6NkY4kcC329kPyUrxTy-k8U63zHEdrroCsgR-HJqJOsH7l0Q&_hsmi=358620418&utm_content=357795978&utm_source=hs_email